JPM · Jpmorgan Chase & Co - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $49.84B | - | $46.43B | $44.91B | $45.31B | - | $42.65B | $50.20B | $41.93B | - |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | - | - | - | - | - | - | - | - | - | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | - | - | - |
| Operating Income | $20.48B | - | $18.74B | $18.28B | $18.41B | - | $16.98B | $23.43B | $17.29B | - |
| Interest Expense | - | - | - | - | - | - | - | - | $24.36B | - |
| Income Tax | $3.98B | - | $4.35B | $3.30B | $3.77B | - | $4.08B | $5.29B | $3.87B | - |
| Net Income | $16.49B | - | $14.39B | $14.99B | $14.64B | - | $12.90B | $18.15B | $13.42B | - |
| EPS - Basic | $5.95 | - | $5.08 | $5.25 | $5.08 | - | $4.38 | $6.13 | $4.45 | - |
| EPS - Diluted | $5.94 | - | $5.07 | $5.24 | $5.07 | - | $4.37 | $6.12 | $4.44 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $312.14B | $343.34B | $303.44B | $420.33B | $425.90B | $469.32B | $434.26B | $530.82B | $562.12B | $624.15B |
| Accounts Receivable | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - | - | - | - | - | - |
| Current Assets | - | - | - | - | - | - | - | - | - | - |
| Total Assets | $4900.48B | $4424.90B | $4560.20B | $4552.48B | $4357.86B | $4002.81B | $4210.05B | $4143.00B | $4090.73B | $3875.39B |
| Current Liabilities | - | - | - | - | - | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $4536.44B | $4062.46B | $4199.99B | $4195.56B | $4006.44B | $3658.06B | $3864.21B | $3802.45B | $3754.09B | $3547.51B |
| Stockholders' Equity | $364.04B | $362.44B | $360.21B | $356.92B | $351.42B | $344.76B | $345.84B | $340.55B | $336.64B | $327.88B |
| Retained Earnings | $428.21B | $416.06B | $407.40B | $397.42B | $386.62B | $376.17B | $365.97B | $356.92B | $342.41B | $332.90B |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($211.76B) | - | - | - | ($251.84B) | - | - | - | ($154.16B) | - |
| Investing Cash Flow | ($217.77B) | - | - | - | ($118.08B) | - | - | - | ($43.38B) | - |
| Financing Cash Flow | $400.68B | - | - | - | $318.06B | - | - | - | $141.17B | - |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 41.1% | - | 40.4% | 40.7% | 40.6% | - | 39.8% | 46.7% | 41.2% | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | 33.1% | - | 31.0% | 33.4% | 32.3% | - | 30.2% | 36.2% | 32.0% | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | 19.5% | - | 23.2% | 18.0% | 20.5% | - | 24.0% | 22.6% | 22.4% | - |
| Return on assets | 0.3% | - | 0.3% | 0.3% | 0.3% | - | 0.3% | 0.4% | 0.3% | - |
| Return on equity | 4.5% | - | 4.0% | 4.2% | 4.2% | - | 3.7% | 5.3% | 4.0% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | - | - | - | - | - | - | - | - | - | - |
| Quick ratio | - | - | - | - | - | - | - | - | - | - |
| Cash ratio | - | - | - | - | - | - | - | - | - | - |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | 0.7x | - |
| Equity multiplier | 13.46 | 12.21 | 12.66 | 12.75 | 12.40 | 11.61 | 12.17 | 12.17 | 12.15 | 11.82 |
| Liabilities / Assets | 0.93 | 0.92 | 0.92 | 0.92 | 0.92 | 0.91 | 0.92 | 0.92 | 0.92 | 0.92 |
| Efficiency | ||||||||||
| Asset turnover | 0.01 | - | 0.01 | 0.01 | 0.01 | - | 0.01 | 0.01 | 0.01 | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | 49.5x | - | 62.2x | 55.3x | 48.4x | - | 48.3x | 33.0x | 45.1x | - |
| P / B | 2.2x | - | 2.4x | 2.3x | 2.0x | - | 1.7x | 1.7x | 1.7x | - |
| P / S | 16.1x | - | 18.8x | 18.0x | 15.3x | - | 14.2x | 11.7x | 13.9x | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 10.0% | - | 8.8% | -10.5% | 8.1% | - | 7.0% | 21.5% | 9.3% | - |
| Revenue CAGR (3y) | 9.1% | - | 12.4% | 13.5% | 13.8% | - | 12.9% | 18.1% | 9.1% | - |
| Revenue CAGR (5y) | 9.1% | - | 9.8% | 6.4% | 9.9% | - | 7.8% | 11.7% | 7.6% | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 11.3% | - | 10.4% | -22.0% | 6.4% | - | 1.5% | 33.3% | 8.3% | - |
| Net income growth (YoY) | 12.6% | - | 11.6% | -17.4% | 9.1% | - | -1.9% | 25.4% | 6.3% | - |
| EPS growth (YoY) | 17.2% | - | 16.0% | -14.4% | 14.2% | - | 0.9% | 28.8% | 8.3% | - |
| EPS CAGR (3y) | 13.2% | - | 17.6% | 23.8% | 24.5% | - | 5.3% | 17.4% | -0.4% | - |
| EPS CAGR (5y) | 5.7% | - | 11.7% | 30.6% | 45.4% | - | 10.3% | 16.8% | 10.9% | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 3.6% | 5.1% | 4.2% | 4.8% | 4.4% | 5.1% | 9.0% | 9.0% | 11.1% | 12.2% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$178.56B totalCommercial And Investment Bank$78.45B · 43.9%
Consumer Community Banking$76.03B · 42.6%
Assetand Wealth Management Segment$24.07B · 13.5%
Geographic
$225.21B totalNorth America$139.69B · 62.0%
Total International$42.76B · 19.0%
EMEA$24.48B · 10.9%
Asia Pacific$14.06B · 6.2%
Latin America$4.21B · 1.9%
Peer comparison
Same SIC group: National Commercial Banks
Comparing JPMORGAN CHASE & CO against the 5 most active filers in the same SIC group.
Dividends
$5.90/share trailing 12 months · +16.8% YoY
| Ex-date | Per share |
|---|---|
| Apr 6, 2026 | $1.5000 |
| Jan 6, 2026 | $1.5000 |
| Oct 6, 2025 | $1.5000 |
| Jul 3, 2025 | $1.4000 |
| Apr 4, 2025 | $1.4000 |
| Jan 6, 2025 | $1.2500 |
| Oct 4, 2024 | $1.2500 |
| Jul 5, 2024 | $1.1500 |
| Apr 4, 2024 | $1.1500 |
| Jan 4, 2024 | $1.0500 |
| Oct 5, 2023 | $1.0500 |
| Jul 5, 2023 | $1.0000 |
| Apr 5, 2023 | $1.0000 |
| Jan 5, 2023 | $1.0000 |
| Oct 5, 2022 | $1.0000 |
| Jul 5, 2022 | $1.0000 |
| Apr 5, 2022 | $1.0000 |
| Jan 5, 2022 | $1.0000 |
| Oct 5, 2021 | $1.0000 |
| Jul 2, 2021 | $0.9000 |
| Apr 5, 2021 | $0.9000 |
| Jan 5, 2021 | $0.9000 |
| Oct 5, 2020 | $0.9000 |
| Jul 2, 2020 | $0.9000 |